Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant

Bone Marrow Transplantation volume 53, pages 1345–1348 (2018)Cite this article

Subjects

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

References

  1. Luznik L, O’Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant. 2008;14:641–650.

    Article  CAS  Google Scholar 

  2. Solomon SR, Sizemore CA, Sanacore M, Zhang X, Brown S, Holland HK, et al. Total body irradiation-based myeloablative haploidentical stem cell transplantation is a safe and effective alternative to unrelated donor transplantation in patients without matched sibling donors. Biol Blood Marrow Transplant. 2015;21:1299–1307.

    Article  Google Scholar 

  3. Gaballa S, Ge I, El Fakih R, Brammer JE, Kongtim P, Tomuleasa C, et al. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation. Cancer. 2016;122:3316–3326.

    Article  CAS  Google Scholar 

  4. Eto M, Mayumi H, Tomita Y, Yoshikai Y, Nishimura Y, Maeda T. et al. Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice. J Immunol. 1991;146:1402–1409.

    CAS  PubMed  Google Scholar 

  5. Bashey A, Solomon SR. T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor. Bone Marrow Transplant. 2014;49:999–1008.

    Article  CAS  Google Scholar 

  6. Grosso D, Carabasi M, Filicko-O’Hara J, Kasner M, Wagner JL, Colombe B, et al. A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing. Blood. 2011;118:4732–4739.

    Article  CAS  Google Scholar 

  7. Aboul Nour H, Patil N, Chewning JH, Di Stasi A, Salzman D, Innis-Shelton R, et al. Safety of repeated un-manipulated peripheral blood stem cell haploidentical transplant for graft failure. Bone Marrow Transplant. 2017;52:157–158.

    Article  CAS  Google Scholar 

  8. Solomon SR, Sizemore CA, Sanacore M, Zhang X, Brown S, Holland HK, et al. Haploidentical transplantation using t-cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free survival: results of a prospective phase II trial. Biol Blood Marrow Transplant. 2012;31:31.

    Google Scholar 

  9. Raiola AM, Dominietto A, Ghiso A, Di Grazia C, Lamparelli T, Gualandi F, et al. Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning. Biol Blood Marrow Transplant. 2013;19:117–122.

    Article  CAS  Google Scholar 

  10. Brunstein CG, Fuchs EJ, Carter SL, Karanes C, Costa LJ, Wu J, et al. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood. 2011;118:282–288.

    Article  CAS  Google Scholar 

  11. Grosso D, Gaballa S, Alpdogan O, Carabasi M, Filicko-O’Hara J, Kasner M, et al. A two-step approach to myeloablative haploidentical transplantation: low non-relapse mortality and high survival confirmed in patients with earlier stage disease. Biol Blood Marrow Transplant. 2015;21:646–652.

    Article  Google Scholar 

  12. Cieri N, Greco R, Crucitti L, Morelli M, Giglio F, Levati G et al. Post-transplant cyclophosphamide and sirolimus after haploidentical HSCT using a treosulfan-based myeloablative conditioning and PBSC. Biol Blood Marrow Transplant. 2015; 21:1506–1514.https://doi.org/10.1016/j.bbmt.2015.04.025

    Article  CAS  Google Scholar 

  13. Schlenk RF, Dohner K, Mack S, Stoppel M, Kiraly F, Gotze K, et al. Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A. J Clin Oncol. 2010;28:4642–4648.

    Article  Google Scholar 

  14. Di Stasi A, Milton DR, Poon LM, Hamdi A, Rondon G, Chen J, et al. Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors. Biol Blood Marrow Transplant. 2014;20:1975–1981.

    Article  Google Scholar 

  15. Raj RV, Hari P, Pasquini M, Epperla N, D’Souza A, Fenske T, et al. Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections. Bone Marrow Transplant. 2016;51:1602–1604.

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Blood and Marrow Transplantation and Cellular Therapy Program, University of Alabama at Birmingham, Birmingham, AL, USA

      Ayman Saad, Alankrita Taneja, Antonio Di Stasi, Rivvi Kukkamalla, Luciano Costa, Donna Salzman, Racquel Innis-Shelton, Samantha Langford, KirbyAnn Plessala, Ravi Bhatia & Lawrence S Lamb

    2. Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA

      Rehan Sarmad

    3. Pediatric Blood and Marrow Transplantation Program, University of Alabama at Birmingham, Birmingham, AL, USA

      Joseph H. Chewning

    4. Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA

      Ruby F. Meredith

    5. Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, USA

      Vera Hauptfeld

    6. Louisiana State University, Baton Rouge, USA

      KirbyAnn Plessala

    7. Blood and Marrow Transplantation Program, Pennsylvania State University, Old Main, PA, 16801, USA

      Shin Mineishi

    Authors
    1. Ayman Saad
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Alankrita Taneja
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Antonio Di Stasi
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Rehan Sarmad
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Rivvi Kukkamalla
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Luciano Costa
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Donna Salzman
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Racquel Innis-Shelton
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. Joseph H. Chewning
      View author publications

      You can also search for this author in PubMed Google Scholar

    10. Ruby F. Meredith
      View author publications

      You can also search for this author in PubMed Google Scholar

    11. Vera Hauptfeld
      View author publications

      You can also search for this author in PubMed Google Scholar

    12. Samantha Langford
      View author publications

      You can also search for this author in PubMed Google Scholar

    13. KirbyAnn Plessala
      View author publications

      You can also search for this author in PubMed Google Scholar

    14. Ravi Bhatia
      View author publications

      You can also search for this author in PubMed Google Scholar

    15. Lawrence S Lamb
      View author publications

      You can also search for this author in PubMed Google Scholar

    16. Shin Mineishi
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Ayman Saad.

    Ethics declarations

    Conflict of Interest

    Ayman Saad: royalty for licensing of intellectual property (Incysus Biomedical), grant support (American Porphyria foundation), consultant fees (Actinium Pharma Inc), Research support (Astellas and Fate Therapeutics), and Honoraria (Alexion and Spectrum Pharmaceutical). Lawrence lamb: Chair, Incysus Scientific Advisory Board. The authors declare that they have no conflict of interest.

    Additional information

    These authors contributed equally: Ayman Saad, Alankrita Taneja.

    Electronic supplementary material

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Saad, A., Taneja, A., Di Stasi, A. et al. Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant. Bone Marrow Transplant 53, 1345–1348 (2018). https://doi.org/10.1038/s41409-018-0185-6

    Download citation

    • Received:

    • Revised:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1038/s41409-018-0185-6

    This article is cited by

    Search

    Advanced search

    Quick links